Article Information
History
- May 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Deya Alkhatiba,*,†,
- Ibrahim Karabayirb,*,
- Issa Pour-Ghaza,
- Sania Khana,
- Linda Hartc,
- Megan Ceased,
- John L Jefferiesa and
- Oguz Akbilgicb
- aThe University of Tennessee Health Science Center – Division of Cardiovascular Disease, Memphis, TN, 38163, USA
- bWake Forest School of Medicine – Section of Cardiovascular Medicine, Winston-Salem, NC, 27157, USA
- cSenior Clinical Education Manager – Nuwellis, Eden Prairie, MN, 55344, USA
- dVice President of Clinical Research – Nuwellis, Plymouth, MN, 55446, USA
- ↵†ADDRESS FOR CORRESPONDANCE:
Deya Alkhatib, MD, The University of Tennessee Health Science Center – Division of Cardiovascular Disease, Memphis, TN 38163, USA, Telephone: 901-448-5750, Fax: 901-448-8084, Email: dalkhati{at}uthsc.edu, Twitter Handle: @Deya_AlkhatibMD
Posted May 08, 2023.
Pretreatment Identification of 90-Day Readmission Among Heart Failure Patients Receiving Aquapheresis Treatment
